The knee reconstruction device market will reach $13.0 billion by 2033, growing at a CAGR of 4.3%.

Knee joint reconstruction devices market

The knee reconstruction device market is on track for significant growth, with a projected market valuation of approximately $8.5 billion by 2023. According to Future Market Insights (FMI), the market is expected to grow at a moderate compound annual growth rate (CAGR) 4.3% from 2023 to 2033, reaching a level of approx. $13.0 billion until the end of 2033.

According to Future Market Insights (FMI), the rapid growth of the knee reconstruction device market can be attributed to significant innovations in product design and functionality. Market participants are benefiting from the rising prevalence of knee-related conditions such as arthritis and knee discomfort, which are driving demand for advanced knee reconstruction solutions.

Request a sample of the detailed report by sending your business email address:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4878

One of the key developments in the knee reconstruction device market is the requirement for advancements in less invasive surgical techniques and materials. These developments aim to improve patient outcomes, reduce surgical complications and shorten recovery times. Additionally, the industry is witnessing an increase in funding for patient-specific knee implants and robotics-assisted surgery, which increase the precision and customization of knee reconstruction procedures.

As the world’s population ages and leads more active lifestyles, the knee reconstruction device market is expected to grow, offering a significant opportunity for the medical device sector. When all is said and done, the knee reconstruction device market is expected to continue to grow as it continues to evolve in response to patient needs and the changing healthcare landscape.

Key takeaways:

By 2033, the global market is estimated to be valued at $13.0 billion at a CAGR of 4.3%.
Historically, the global market recorded a CAGR of 2.8% between 2018 and 2022.
It is estimated that the United States will dominate the global market, gaining a share of 29.5% by 2033.
Germany is estimated to have an 8.1% share of the global market during the forecast period.
Japan is expected to secure a global market share of 5.0% during the forecast period.
Australia is expected to drive the global market by 2033 at a CAGR of 4.4%.

Competitive landscape in the knee reconstruction devices market

Globally, there is moderate market concentration in the knee reconstruction devices industry, with a few companies expected to account for the majority of sales. Market leaders are devoting more resources to research and development to create innovative products and achieve regulatory approval faster to increase market share of their knee reconstruction devices.

Last changes

As part of its development of a connected technology digital surgery platform, Johnson & Johnson Medical Devices Company (J&JMD) announced in January 2021 that the FDA has cleared its robot-assisted VELYS solution with the Attune Total Knee System.

Active Technologies received FDA approval in March 2021 for its Citrespline and Citrelock ligament reconstruction devices, which are designed to prevent soft tissue damage during insertion. These devices can be used for reconstructive procedures on various joints, including the knee joint.

In addition, Conformis Inc. has announced that its iTotal PS patient-specific total knee replacement system has been approved by the Australian Therapeutic Goods Agency. The technology is designed to provide patients with a reconstructive process that is unique to their body.

Customization available:
https://www.futuremarketinsights.com/customization-available/REP-GB-4878

Key company profiles:

Zimmer, Inc.
Stryker company
DePuy’s Synthes
Smith and nephew
Korin
Great Orthopedic Corporation
Artrex company.
The company Exactech sp.
Global DJO
Dynamic medical marketing in Japan
Tornier Inc.

Knee joint reconstruction devices market by segmentation:

By product:

Cement implants
Cementless implants
Partial implants
Revision implants

By end user:

Hospitals
Orthopedic clinics
ASC

By indication:

Osteoarthritis
Rheumatoid arthritis
Injury
Others

By region:

North America
Latin America
Europe
eastern Asia
southern Asia
Oceania
Middle East and Africa (MEA)

Get the full market intelligence overview: Buy now to get access:
https://www.futuremarketinsights.com/checkout/4878

Future Market Intelligence Information (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award winner and member of the Greater New York Chamber of Commerce) offers in-depth knowledge of the drivers of market demand. FMI is a leading global provider of market information, advisory, consulting and events services for the packaging, food and beverage, consumer technology, healthcare, industrial and chemicals markets. With a massive team of over 400 analysts worldwide, FMI provides global, regional and local expertise in a variety of domains and industry trends in over 110 countries.

Contact us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Apartment 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For sales inquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | Youtube